United Therapeutics (UTHR) Tops Q1 EPS by 38c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $536.59 -2.7%
EPS Growth %: +12.6%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +12.6%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $6.17, $0.38 better than the analyst estimate of $5.79. Revenue for the quarter came in at $677.7 million versus the consensus estimate of $620.31 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Goldman starts Talen at buy, sees PJM power tightness boosting earnings
- Pfizer reaffirms 2026 guidance after CFO transition news
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
